What is the classification of teicoplanin?
•
3 min read
First isolated in 1978, teicoplanin is a semisynthetic glycopeptide antibiotic that is effective against severe Gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). This critical medication works by inhibiting the synthesis of the bacterial cell wall.
